Aberrant human gastric response to secretin.
D000328:Adult; D000368:Aged; D004381:Duodenal Ulcer / Q000503:physiopathology*; D004386:Duodenum / Q000378:metabolism; D005745:Gastric Acidity Determination; D005753:Gastric Mucosa / Q000187:drug effects* / Q000503:physiopathology*; D005756:Gastritis / Q000503:physiopathology; D005773:Gastroscopy; D006018:Glycols / Q000494:pharmacology; D006632:Histamine / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006984:Hypertrophy / Q000503:physiopathology; D007275:Injections, Intravenous; D007419:Intestinal Secretions / Q000032:analysis; D008297:Male; D008875:Middle Aged; D012463:Saliva / Q000032:analysis; D012633:Secretin / Q000008:administration & dosage / Q000494:pharmacology*; D012636:Secretory Rate / Q000187:drug effects; D013268:Stimulation, Chemical
D006018:Glycols; D012633:Secretin; D006632:Histamine